Registro:

Referencias:

• Orange, J.S., Natural killer cell deficiency (2013) J Allergy Clin Immunol, 132, pp. 515-525
• Lanier, L.L., Evolutionary struggles between NK cells and viruses (2008) Nat Rev Immunol, 8, pp. 259-268
• Moretta, A., Marcenaro, E., Parolini, S., Ferlazzo, G., Moretta, L., NK cells at the interface between innate and adaptive immunity (2008) Cell Death Differ, 15, pp. 226-233
• Imai, K., Matsuyama, S., Miyake, S., Suga, K., Nakachi, K., Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population (2000) Lancet, 356, pp. 1795-1799
• Freud, A.G., Mundy-Bosse, B.L., Yu, J., Caligiuri, M.A., The broad spectrum of human natural killer cell diversity (2017) Immunity, 47, pp. 820-833
• Melsen, J.E., Lugthart, G., Lankester, A.C., Schilham, M.W., Human circulating and tissue-resident CD56(bright) natural killer cell populations (2016) Front Immunol, 7, p. 262
• De Maria, A., Bozzano, F., Cantoni, C., Moretta, L., Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation (2011) Proc Natl Acad Sci U S A, 108, pp. 728-732
• Domaica, C.I., Fuertes, M.B., Uriarte, I., Girart, M.V., Sardanons, J., Comas, D.I., Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development (2012) PLoS One, 7
• Dulphy, N., Haas, P., Busson, M., Belhadj, S., Peffault de Latour, R., Robin, M., An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation (2008) J Immunol, 181, pp. 2227-2237
• Fehniger, T.A., Cooper, M.A., Nuovo, G.J., Cella, M., Facchetti, F., Colonna, M., CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity (2003) Blood, 101, pp. 3052-3057
• Angelo, L.S., Banerjee, P.P., Monaco-Shawver, L., Rosen, J.B., Makedonas, G., Forbes, L.R., Practical NK cell phenotyping and variability in healthy adults (2015) Immunol Res, 62, pp. 341-356
• Beziat, V., Duffy, D., Quoc, S.N., Le Garff-Tavernier, M., Decocq, J., Combadiere, B., CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation (2011) J Immunol, 186, pp. 6753-6761
• Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., CD56brightCD16-killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation (2007) J Immunol, 178, pp. 4947-4955
• Silva, A., Andrews, D.M., Brooks, A.G., Smyth, M.J., Hayakawa, Y., Application of CD27 as a marker for distinguishing human NK cell subsets (2008) Int Immunol, 20, pp. 625-630
• Vossen, M.T., Matmati, M., Hertoghs, K.M., Baars, P.A., Gent, M.R., Leclercq, G., CD27 defines phenotypically and functionally different human NK cell subsets (2008) J Immunol, 180, pp. 3739-3745
• Fu, B., Wang, F., Sun, R., Ling, B., Tian, Z., Wei, H., CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells (2011) Immunology, 133, pp. 350-359
• Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., Walzer, T., Maturation of mouse NK cells is a 4-stage developmental program (2009) Blood, 113, pp. 5488-5496
• Hayakawa, Y., Smyth, M.J., CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity (2006) J Immunol, 176, pp. 1517-1524
• Caligiuri, M.A., Zmuidzinas, A., Manley, T.J., Levine, H., Smith, K.A., Ritz, J., Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors (1990) J Exp Med, 171, pp. 1509-1526
• Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset (2001) Blood, 97, pp. 3146-3151
• Nagler, A., Lanier, L.L., Phillips, J.H., Constitutive expression of high affinity interleukin 2 receptors on human CD16-natural killer cells in vivo (1990) J Exp Med, 171, pp. 1527-1533
• Rossi, L.E., Avila, D.E., Spallanzani, R.G., Ziblat, A., Fuertes, M.B., Lapyckyj, L., Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression (2012) J Leukoc Biol, 91, pp. 321-331
• Ziblat, A., Domaica, C.I., Spallanzani, R.G., Iraolagoitia, X.L., Rossi, L.E., Avila, D.E., IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness (2015) Eur J Immunol, 45, pp. 192-202
• Boyman, O., Sprent, J., The role of interleukin-2 during homeostasis and activation of the immune system (2012) Nat Rev Immunol, 12, pp. 180-190
• Yu, C.R., Young, H.A., Ortaldo, J.R., Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells (1998) J Leukoc Biol, 64, pp. 245-258
• Delespine-Carmagnat, M., Bouvier, G., Bertoglio, J., Association of STAT1, STAT3 and STAT5 proteins with the IL-2 receptor involves different subdomains of the IL-2 receptor beta chain (2000) Eur J Immunol, 30, pp. 59-68
• Jenks, J.A., Seki, S., Kanai, T., Huang, J., Morgan, A.A., Scalco, R.C., Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells (2013) Clin Immunol, 148, pp. 227-236
• Voss, M., Bryceson, Y.T., Natural killer cell biology illuminated by primary immunodeficiency syndromes in humans (2017) Clin Immunol, 177, pp. 29-42
• Mace, E.M., Orange, J.S., Genetic causes of human NK cell deficiency and their effect on NK cell subsets (2016) Front Immunol, 7, p. 545
• Sharfe, N., Dadi, H.K., Shahar, M., Roifman, C.M., Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor (1997) Proc Natl Acad Sci U S A, 94, pp. 3168-3171
• Mace, E.M., Orange, J.S., Lytic immune synapse function requires filamentous actin deconstruction by Coronin 1A (2014) Proc Natl Acad Sci U S A, 111, pp. 6708-6713
• Mace, E.M., Hsu, A.P., Monaco-Shawver, L., Makedonas, G., Rosen, J.B., Dropulic, L., Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset (2013) Blood, 121, pp. 2669-2677
• Casanova, J.L., Abel, L., Human genetics of infectious diseases: unique insights into immunological redundancy (2017) Semin Immunol, 36, pp. 1-12
• Fischer, A., Rausell, A., Primary immunodeficiencies suggest redundancy within the human immune system (2016) Sci Immunol, 1 (6)
• Rezaei, N., Aghamohammadi, A., Notarangelo, L., (2017) Primary Immunodeficiency Diseases: Definition, Diagnosis, and Management, , 2nd ed. Berlin, Heidelberg: Springer-Verlag
• Caudy, A.A., Reddy, S.T., Chatila, T., Atkinson, J.P., Verbsky, J.W., CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes (2007) J Allergy Clin Immunol, 119, pp. 482-487
• Goudy, K., Aydin, D., Barzaghi, F., Gambineri, E., Vignoli, M., Ciullini Mannurita, S., Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity (2013) Clin Immunol, 146, pp. 248-261
• Bezrodnik, L., Caldirola, M.S., Seminario, A.G., Moreira, I., Gaillard, M.I., Follicular bronchiolitis as phenotype associated with CD25 deficiency (2014) Clin Exp Immunol, 175, pp. 227-234
• Kanai, T., Jenks, J., Nadeau, K.C., The STAT5b pathway defect and autoimmunity (2012) Front Immunol, 3, p. 234
• Bezrodnik, L., Di Giovanni, D., Caldirola, M.S., Azcoiti, M.E., Torgerson, T., Gaillard, M.I., Long-term follow-up of STAT5B deficiency in three argentinian patients: clinical and immunological features (2015) J Clin Immunol, 35, pp. 264-272
• Scaglia, P.A., Martinez, A.S., Feigerlova, E., Bezrodnik, L., Gaillard, M.I., Di Giovanni, D., A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease (2012) J Clin Endocrinol Metab, 97 (5), pp. E830-E839
• Szabo, S.J., Sullivan, B.M., Stemmann, C., Satoskar, A.R., Sleckman, B.P., Glimcher, L.H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells (2002) Science, 295 (5553), pp. 338-342
• Bustamante, J., Boisson-Dupuis, S., Abel, L., Casanova, J.L., Mendelian susceptibility to mycobacterial disease: genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity (2014) Semin Immunol, 26 (6), pp. 454-470
• Crome, S.Q., Lang, P.A., Lang, K.S., Ohashi, P.S., Natural killer cells regulate diverse T cell responses (2013) Trends Immunol, 34, pp. 342-349
• Moretta, L., Dissecting CD56dim human NK cells (2010) Blood, 116, pp. 3689-3691
• Bjorkstrom, N.K., Riese, P., Heuts, F., Andersson, S., Fauriat, C., Ivarsson, M.A., Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education (2010) Blood, 116, pp. 3853-3864
• Lopez-Verges, S., Milush, J.M., Pandey, S., York, V.A., Arakawa-Hoyt, J., Pircher, H., CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset (2010) Blood, 116, pp. 3865-3874
• Kared, H., Martelli, S., Ng, T.P., Pender, S.L., Larbi, A., CD57 in human natural killer cells and T-lymphocytes (2016) Cancer Immunol Immunother, 65, pp. 441-452
• Pesce, S., Moretta, L., Moretta, A., Marcenaro, E., Human NK cell subsets redistribution in pathological conditions: a role for CCR7 receptor (2016) Front Immunol, 7, p. 414
• Gregoire, C., Chasson, L., Luci, C., Tomasello, E., Geissmann, F., Vivier, E., The trafficking of natural killer cells (2007) Immunol Rev, 220, pp. 169-182
• Frey, M., Packianathan, N.B., Fehniger, T.A., Ross, M.E., Wang, W.C., Stewart, C.C., Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets (1998) J Immunol, 161, pp. 400-408
• Victor, A.R., Weigel, C., Scoville, S.D., Chan, W.K., Chatman, K., Nemer, M.M., Epigenetic and posttranscriptional regulation of CD16 expression during human NK cell development (2018) J Immunol, 200, pp. 565-572

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------